tldrdailynews.com logo

"Zepbound: Promising Treatment for Obstructive Sleep Apnea Trials"

1 min read
Source: STAT
"Zepbound: Promising Treatment for Obstructive Sleep Apnea Trials"
Photo: STAT
TL;DR

Eli Lilly's obesity drug Zepbound has shown positive results in treating obstructive sleep apnea (OSA) in a Phase 3 study, potentially positioning it as the first approved treatment for OSA. Patients taking Zepbound experienced a significant reduction in the apnea-hypopnea index compared to those on a placebo, indicating its potential to address breathing interruptions during sleep in individuals with obesity.

Topics:businesshealth#eli-lilly#health#obesity-drug#obstructive-sleep-apnea#phase-3-study#zepbound
Share this article
  1. Zepbound effective in obstructive sleep apnea trials - STAT  STAT
  2. Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says  CNN
  3. Eli Lilly drug Zepbound: Will it help my obstructive sleep apnea?  Fast Company
  4. ASML Stock Dives. Chip Makers Are Cautious.  Barron's
  5. Zepbound, Eli Lilly obesity drug, promising treatment for sleep apnea  USA TODAY

Want the full story? Read the original reporting

Read on STAT